唑尼沙胺
唑尼沙胺(英語:)是一种磺胺类抗惊厥药,被批准用于辅助治疗成人的癫痫发作,婴儿的韋斯特綜合症,伦诺克斯-加斯托二氏综合征、肌阵挛和全身强直-阵挛性发作[2]。
![]() | |
![]() | |
| 系统(IUPAC)命名名称 | |
|---|---|
benzo[d]isoxazol-3-ylmethanesulfonamide | |
| 临床数据 | |
| 商品名 | Zonegran |
| Drugs.com | Monograph |
| MedlinePlus | a603008 |
| 妊娠分级 | |
| 给药途径 | Oral |
| 合法狀態 | |
| 合法状态 |
|
| 药代动力学数据 | |
| 生物利用度 | ~100%[1] |
| 蛋白结合度 | 40%[1] |
| 代谢 | Hepatic through CYP3A4[1] |
| 生物半衰期 | 63 hours in plasma[1] |
| 排泄 | Renal (62%); Faeces (3%)[1] |
| 识别 | |
| CAS注册号 | 68291-97-4 |
| ATC代码 | N03AX15 |
| PubChem | CID 5734 |
| DrugBank | DB00909 |
| ChemSpider | 5532 |
| UNII | 459384H98V |
| KEGG | D00538 |
| ChEBI | CHEBI:10127 |
| ChEMBL | CHEMBL750 |
| PDB配体ID | ZON (PDBe, RCSB PDB) |
| 化学 | |
| 化学式 | C8H8N2O3S |
| 摩尔质量 | 212.227 g/mol |
| |
| |
| 物理性质 | |
| 熔点 | 162 °C(324 °F) |
参考文献
- (PDF). TGA eBusiness Services. SciGen (Australia) Pty Ltd. 4 April 2013 [18 November 2013]. (原始内容存档于2018-10-15).
- Comprehensive Pharmacy Review, Leon Shargel, 6th edition, p988
外部链接
- Official Eisai Website 页面存档备份,存于
- Dainippon Sumitomo Prescribing Information for Excegran (Japanese version)
- Official Dainippon Sumitomo Pharma Website (English version)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

